Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’
Journal of Neuromuscular Diseases · 2023
DOI: 10.3233/jnd-221639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, 2023. Verfasst von Angela Lek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Muscular Dystrophy Association, Chicago, IL, USA. Hauptthemen laut MEDLINE: Muscular Dystrophies, Neuromuscular Diseases. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Muscular Dystrophy Association (MDA) has invested over $125M in the development of gene therapy for neuromuscular disorders (NMD) over the past 20 years. As a lead initiator of progress in this important field of medicine and to help ensure continued progress towards therapies for patients, MDA organized a dedicated summit in January 2022 to address emerging challenges in safely delivering adeno-associated virus (AAV) mediated gene therapies with a focus on their application in NMD. In this meeting, chaired by Carsten Bönnemann (NINDS, NIH) and Barry Byrne (University of Florida), academic and industry experts and stakeholders convened to openly discuss adverse events linked to clinical trials, as well as other challenges emerging in preclinical studies associated with difficulties in the translation of AAV-mediated gene therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Muscular Dystrophy Association, Chicago, IL, USA.
- Powell Gene Therapy Center, University of Florida, Gainesville, FL, USA.
- Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Zitieren
APA
Lek, A., Atas, E., Hesterlee, S. E., Byrne, B. J., & Bönnemann, C. G. (2023). Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-221639
Vancouver
Lek A, Atas E, Hesterlee SE, Byrne BJ, Bönnemann CG. Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’. Journal of Neuromuscular Diseases. 2023. doi:10.3233/jnd-221639
BibTeX
@article{Lek2023,
author = {Lek, Angela and Atas, Evrim and Hesterlee, Sharon E and Byrne, Barry J and Bönnemann, Carsten G},
title = {Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’},
journal = {Journal of Neuromuscular Diseases},
year = {2023},
doi = {10.3233/jnd-221639}
}
EUVIMED